JP6590801B2 - 神経学的疾患のイメージング - Google Patents

神経学的疾患のイメージング Download PDF

Info

Publication number
JP6590801B2
JP6590801B2 JP2016528546A JP2016528546A JP6590801B2 JP 6590801 B2 JP6590801 B2 JP 6590801B2 JP 2016528546 A JP2016528546 A JP 2016528546A JP 2016528546 A JP2016528546 A JP 2016528546A JP 6590801 B2 JP6590801 B2 JP 6590801B2
Authority
JP
Japan
Prior art keywords
ratio
normal
subject
imaging
striatum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016528546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016531903A (ja
JP2016531903A5 (OSRAM
Inventor
ロッサー，マーク・ジョゼフ
ウォルバー，ジャン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of JP2016531903A publication Critical patent/JP2016531903A/ja
Publication of JP2016531903A5 publication Critical patent/JP2016531903A5/ja
Application granted granted Critical
Publication of JP6590801B2 publication Critical patent/JP6590801B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/501—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Neurosurgery (AREA)
  • Dentistry (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine (AREA)
  • Pulmonology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
JP2016528546A 2013-07-25 2014-07-25 神経学的疾患のイメージング Active JP6590801B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1313291.5 2013-07-25
GBGB1313291.5A GB201313291D0 (en) 2013-07-25 2013-07-25 Imaging neurological disease
PCT/EP2014/066042 WO2015011267A1 (en) 2013-07-25 2014-07-25 Imaging neurological disease

Publications (3)

Publication Number Publication Date
JP2016531903A JP2016531903A (ja) 2016-10-13
JP2016531903A5 JP2016531903A5 (OSRAM) 2019-01-17
JP6590801B2 true JP6590801B2 (ja) 2019-10-16

Family

ID=49166921

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016528546A Active JP6590801B2 (ja) 2013-07-25 2014-07-25 神経学的疾患のイメージング

Country Status (16)

Country Link
US (1) US11051777B2 (OSRAM)
EP (1) EP3024501B1 (OSRAM)
JP (1) JP6590801B2 (OSRAM)
KR (1) KR102340504B1 (OSRAM)
CN (1) CN105392500B (OSRAM)
AU (2) AU2014294983B2 (OSRAM)
BR (1) BR112016001316B1 (OSRAM)
CA (1) CA2916125A1 (OSRAM)
DK (1) DK3024501T3 (OSRAM)
ES (1) ES2722973T3 (OSRAM)
GB (1) GB201313291D0 (OSRAM)
IL (1) IL243383B (OSRAM)
MX (1) MX2016001012A (OSRAM)
RU (1) RU2015155792A (OSRAM)
SG (1) SG11201600571RA (OSRAM)
WO (1) WO2015011267A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104720840A (zh) * 2015-02-11 2015-06-24 清华大学深圳研究生院 基于多巴胺转运体显像特异性摄取比的半自动量化方法
TWI587841B (zh) * 2015-03-06 2017-06-21 國立陽明大學 定量分析核子醫學腦部影像的系統及方法
KR20170131829A (ko) * 2015-03-24 2017-11-30 니혼 메디피직스 가부시키가이샤 화상 처리 장치, 화상 처리 방법, 및 프로그램
KR101720288B1 (ko) 2016-05-11 2017-03-28 (주)바이오액츠 뇌 영상용 염료 및 이의 제조방법
JP6549521B2 (ja) * 2016-05-25 2019-07-24 富士フイルム富山化学株式会社 疾患鑑別支援装置及びコンピュータプログラム
TWI607739B (zh) * 2016-05-27 2017-12-11 許百靈 Ｓｐｅｃｔ多巴胺顯像定量分析技術與在腦多巴胺評估的用途
GB201621698D0 (en) * 2016-12-20 2017-02-01 Ge Healthcare Ltd (Ip) And Stichting Vumc And Acad Medical Center Differential Diagnosis
JP6995642B2 (ja) * 2018-01-19 2022-01-14 日本メジフィジックス株式会社 画像処理装置、画像処理方法およびプログラム
TWI686178B (zh) 2019-10-09 2020-03-01 中原大學 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統
WO2021102323A1 (en) * 2019-11-21 2021-05-27 Likeminds, Inc. Pharmaceutical packaging units and methods for concomitant administration of radiotracers
PE20240822A1 (es) 2021-03-22 2024-04-18 Neurocrine Biosciences Inc Inhibidores de vmat2 y metodos de uso
JP7834281B2 (ja) * 2022-02-18 2026-03-24 社会福祉法人兵庫県社会福祉事業団 画像処理プログラム、画像処理方法、および画像処理装置
CN119599879B (zh) * 2024-11-06 2025-10-24 复旦大学附属华山医院 一种基于深度学习的pet图像跨膜态合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010540512A (ja) * 2007-09-26 2010-12-24 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 異なるタイプの認知症を特異的に診断する方法
US8084018B2 (en) * 2007-10-31 2011-12-27 Alseres Pharmaceuticals, Inc. Methods for imaging dopamine transporter level
CA2703563A1 (en) * 2007-10-31 2009-05-07 Alseres Pharmaceuticals, Inc. Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level

Also Published As

Publication number Publication date
EP3024501A1 (en) 2016-06-01
AU2019253837B2 (en) 2021-11-25
CN105392500A (zh) 2016-03-09
EP3024501B1 (en) 2019-03-27
SG11201600571RA (en) 2016-02-26
CN105392500B (zh) 2023-08-18
RU2015155792A (ru) 2017-08-30
US20160183897A1 (en) 2016-06-30
JP2016531903A (ja) 2016-10-13
US11051777B2 (en) 2021-07-06
WO2015011267A1 (en) 2015-01-29
KR20160037168A (ko) 2016-04-05
DK3024501T3 (da) 2019-05-06
AU2019253837A1 (en) 2019-11-14
AU2014294983B2 (en) 2019-10-24
MX2016001012A (es) 2016-05-09
BR112016001316B1 (pt) 2021-04-06
AU2014294983A1 (en) 2016-01-21
RU2015155792A3 (OSRAM) 2018-05-23
HK1222118A1 (zh) 2017-06-23
ES2722973T3 (es) 2019-08-20
CA2916125A1 (en) 2015-01-29
IL243383B (en) 2018-07-31
KR102340504B1 (ko) 2021-12-20
GB201313291D0 (en) 2013-09-11

Similar Documents

Publication Publication Date Title
AU2014294983B2 (en) Imaging neurological disease
Guedj et al. EANM procedure guidelines for brain PET imaging using [18F] FDG, version 3
Mountz et al. Comparison of qualitative and quantitative imaging characteristics of [11C] PiB and [18F] flutemetamol in normal control and Alzheimer's subjects
US10657645B2 (en) Voxel-based methods for assessing subjects using molecular magnetic resonance imaging
Park et al. 11C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas
Lin et al. Imaging characteristic of dual-phase 18F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer’s disease and mild cognitive impairment
Eusebio et al. Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects
Upadhyaya et al. A study of depression in old age using single-photon emission computerised tomography
Hsiao et al. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson’s disease patients
JP2011502966A5 (OSRAM)
JP2011502966A (ja) ドーパミントランスポーターレベルを評価することによるレビー小体型認知症の診断およびレビー小体型認知症の処置のモニタリングのための方法
JP2014148529A (ja) ドーパミン輸送体レベルを造影するための方法
Gray et al. Kinetic filtering of [18F] fluorothymidine in positron emission tomography studies
Booij et al. Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible
Edison et al. Strategies for the generation of parametric images of [11C] PIB with plasma input functions considering discriminations and reproducibility
Wells et al. Comparison of attenuation, dual-energy-window, and model-based scatter correction of low-count SPECT to 82Rb PET/CT quantified myocardial perfusion scores
Meyer et al. Kinetic analyses of [123I] IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach
Chua et al. Technetium-99m teboroxime regional myocardial washout in subjects with and without coronary artery disease
Prando et al. Methods for quantification of cerebral glycolytic metabolism using 2-deoxy-2-[18 F] fluoroglucose in small animals
Edison et al. Technical aspects of amyloid imaging for Alzheimer's disease
Bros et al. Effects of carbidopa premedication on 18F-FDOPA PET imaging of brain tumors: a static, dynamic and radiomics analysis
HK1222118B (zh) 成像神经学疾病
Buratachwatanasiri The pharmacokinetic model of 18F-FDOPA in PET brain imaging for early Parkinson s disease
Ponto Positron Emission Tomography (PET) Imaging: Principles and Potential Role in Understanding Brain Function
Zhang et al. The Effect of the Presence of EEG Leads on Image Quality in Cerebral Perfusion SPECT and FDG PET/CT

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170711

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180821

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181120

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20181120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190212

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190315

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20190605

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190801

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190820

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190917

R150 Certificate of patent or registration of utility model

Ref document number: 6590801

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250